Jefferies Reiterates a 'Buy' on Express Scripts (ESRX); Real Boost From MHS Acquisition

Jefferies reiterates a 'Buy' on Express Scripts (NASDAQ: ESRX) price target raised from $60 to $68.

Analyst, Arthur I. Henderson, said, "We believe ESRX's earnings outlook has brightened considerably with the acquisition of Medco Health Solutions. No FTC conditions means that projected synergies, currently pegged at $1B, could easily move higher in the coming months."

Jefferies raises FY12 EPS estimate from $3.49 to $3.59.

For an analyst ratings summary and ratings history on Express Scripts click here. For more ratings news on Express Scripts click here.

Shares of Express Scripts closed at $57.67 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results